Global expansion Sirio Pharma’s ongoing manufacturing expansion in Thailand and its presence across China, Germany, and the United States, plus its strategy to serve over 50 countries, signals opportunities to offer regional supply chain optimization, local regulatory support, and diversified manufacturing capacity for new or existing customers expanding in Asia-Pacific and North America.

Diverse delivery With capabilities across gummies, softgels, capsules, tablets, powders, functional beverages, probiotics, and other dosage forms, there is a strong potential to co-develop customized nutraceutical SKUs for clients seeking multi-format portfolios and faster time to market.

Strategic partnerships Recent collaborations with Lubrizol, Omni Active Technologies, Vitamin Angels, and participation in leading trade events indicate a proactive stance on technology-sharing, science-backed formulations, and social impact positioning that can be leveraged to pitch joint development programs and premium partnerships.

Scale and capability Acquisition of Best Formulations and multi-site manufacturing with global certifications (GMP, TGA, c-GMP, BRCGS, NSF, Halal) suggest robust quality and capacity, enabling sales conversations around high-volume production, regulatory compliance, and reliable supply for private-label or co-branded lines.

Innovation focus Launch of the Sirio Institute for Anti-Ageing and eye-health soft chews, plus a focus on microencapsulation and visible-wellness concepts, point to opportunities to position Sirio as a source for breakthrough, science-backed nutraceuticals and value-added formats for premium retailers and clinical channels.